Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 CAD | +1.25% | +1.25% | -34.41% |
Sales 2024 * | 154M 113M | Sales 2025 * | 155M 113M | Capitalization | 39.13M 28.67M |
---|---|---|---|---|---|
Net income 2024 * | -1M -733K | Net income 2025 * | 1M 733K | EV / Sales 2024 * | 0.25 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.25 x |
P/E ratio 2024 * |
-22.4
x | P/E ratio 2025 * |
27
x | Employees | 98 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.04% |
Latest transcript on Medexus Pharmaceuticals Inc.
1 day | +1.25% | ||
1 week | +1.25% | ||
Current month | -10.99% | ||
3 months | -7.43% | ||
6 months | +6.58% | ||
Current year | -34.41% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-10-15 | |
Marcel Konrad
DFI | Director of Finance/CFO | 49 | 21-07-18 |
Richard Labelle
COO | Chief Operating Officer | - | 14-02-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-06-24 |
Michael Mueller
CHM | Chairman | 64 | 14-05-30 |
Benoit Gravel
BRD | Director/Board Member | - | 17-09-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.62 | +1.25% | 51 882 |
24-05-17 | 1.6 | -1.23% | 2,725 |
24-05-16 | 1.62 | +0.62% | 42,000 |
24-05-15 | 1.61 | +0.63% | 35,699 |
24-05-14 | 1.6 | -3.61% | 30,510 |
Delayed Quote Toronto S.E., May 21, 2024 at 09:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.41% | 28.76M | |
+37.15% | 705B | |
+32.42% | 583B | |
-3.11% | 364B | |
+20.18% | 332B | |
+5.69% | 291B | |
+16.81% | 238B | |
-3.60% | 210B | |
+10.46% | 209B | |
+9.39% | 169B |
- Stock Market
- Equities
- MDP Stock